Period of time： 2013年5期
Publisher： Future Science
Founded in： 2012
Total resources： 5
ISSN： 2046-8954
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Pharmaceutical Patent Analyst,volume 2,issue 5
Menu
Proposals to broaden the UK bolar defence
Pharmaceutical Patent Analyst,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.
Access to resources
Recommend
Parallel imports in the enlarged EU: the specific mechanism
By Stothers Christopher in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.Practical implications of the unitary patent system in Europe
By Bassil Nick,Venner Julia in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.By Dent Jennifer,Ramamoorthi Roopa,Graef Katy,Nelson Lisa Marie,Wichard Johannes Christian in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.Cases Update: International roundup of recently filed cases and noteworthy rulings
By Sklan Alexandra,Komatani Takeshi S in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.A new patent-based approach for technology mapping in the pharmaceutical domain
By Russo Davide,Montecchi Tiziano,Carrara Paolo in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.Engineered antibody variable and constant domains as therapeutic candidates
By Gong Rui,Xiao Gengfu in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.
Previous
Next